Delivery Order SPE2DB22D1200-SPE2DB24FN1PM

Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $6.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $1,524.46 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 mcg inhaler, 12 gm. This order, which has an ultimate completion date of October 11, 2024, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The IDC, held by AmerisourceBergen, enables the DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,240 units of the prescription drug Advair HFA 230-21 MCG Inhaler 12GM. The contract has a completion date of February 6, 2024 and a potential value of $6,901.94. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. This...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,041.32 to provide 4,564,171,744 units of the pharmaceutical product Advair HFA 115-21 MCG Inhaler 12GM. The contract has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
The Defense Logistics Agency (DLA) awarded a $4,866.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,248,106 units of the Advair HFA 115-21 MCG inhaler (12 gram). This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued at up to $999,999,999.00 and effective through December 31, 2025. The IDC serves as the...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,431.62 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, with a performance period through April 11, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,029,522 units of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The award, with a ceiling value of $1,422.58, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and operates under an indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,261,619 units of the pharmaceutical product Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $19,030.95 and a period of performance through April 15, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 mcg inhalers. The $2,706.60 contract has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $7,982.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit organization. The delivery order is for the supply of Advair HFA 230-21 mcg inhaler, 12 gm. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00, to provide a comprehensive range of pharmaceuticals and...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN1PM
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $6,247.92 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,110,395 units of the pharmaceutical product Advair HFA 115-21 MCG Inhaler 12GM. The delivery order has an ultimate completion date of March 29, 2024. This delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC, awarded solely to AmerisourceBergen Drug Corp, serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 6/27/24, 10:10 AM